Candriam S.C.A. Acquires 33,180 Shares of Docusign Inc. $DOCU

Candriam S.C.A. raised its holdings in shares of Docusign Inc. (NASDAQ:DOCU) by 65.1% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 84,116 shares of the company’s stock after purchasing an additional 33,180 shares during the period. Candriam S.C.A.’s holdings in Docusign were worth $6,552,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in DOCU. American Century Companies Inc. grew its stake in shares of Docusign by 3.1% in the 1st quarter. American Century Companies Inc. now owns 5,477,758 shares of the company’s stock worth $445,890,000 after buying an additional 162,299 shares during the last quarter. Geode Capital Management LLC raised its stake in Docusign by 1.5% during the second quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company’s stock valued at $309,910,000 after buying an additional 59,941 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Docusign by 18.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company’s stock worth $165,120,000 after acquiring an additional 318,698 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Docusign by 372.5% in the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company’s stock worth $148,714,000 after acquiring an additional 1,440,269 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Docusign by 6.7% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,431,901 shares of the company’s stock worth $116,557,000 after acquiring an additional 89,948 shares during the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, CFO Blake Jeffrey Grayson sold 9,509 shares of the firm’s stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total value of $790,197.90. Following the transaction, the chief financial officer directly owned 112,160 shares in the company, valued at $9,320,496. This trade represents a 7.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Robert Chatwani sold 13,817 shares of the company’s stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total value of $1,148,192.70. Following the sale, the insider owned 71,162 shares of the company’s stock, valued at approximately $5,913,562.20. This trade represents a 16.26% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 102,533 shares of company stock worth $7,709,933. Insiders own 1.01% of the company’s stock.

Docusign Stock Up 1.1%

Shares of DOCU stock opened at $67.76 on Friday. The company has a 50 day moving average price of $73.98 and a 200-day moving average price of $77.17. Docusign Inc. has a 52 week low of $65.84 and a 52 week high of $107.86. The firm has a market capitalization of $13.63 billion, a PE ratio of 50.95, a P/E/G ratio of 3.33 and a beta of 1.01.

Docusign (NASDAQ:DOCU) last issued its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company had revenue of $800.64 million for the quarter, compared to analysts’ expectations of $780.35 million. During the same quarter last year, the company posted $0.97 earnings per share. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on DOCU shares. Wall Street Zen upgraded shares of Docusign from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Zacks Research raised shares of Docusign from a “hold” rating to a “strong-buy” rating in a report on Tuesday, September 9th. Argus reiterated a “hold” rating on shares of Docusign in a report on Monday, September 8th. Wells Fargo & Company raised their price target on shares of Docusign from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Friday, September 5th. Finally, JPMorgan Chase & Co. upped their price objective on Docusign from $77.00 to $80.00 and gave the company a “neutral” rating in a research report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fifteen have issued a Hold rating to the stock. According to data from MarketBeat, Docusign currently has an average rating of “Hold” and an average target price of $94.14.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.